|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2288727 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09747492.8 |
| Europos patento paraiškos padavimo data | 2009-05-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/043823 |
| Data | 2009-05-13 |
| (87) | Numeris | WO 2009/140409 |
| Data | 2009-11-19 |
| (30) | Numeris | Data | Šalis |
| 127816 P | 2008-05-14 | US |
| (72) |
BAKER, Joffre, B., US
WATSON, Drew, US
MADDALA, Tara, US
SHAK, Steven, US
MAURO, David, J., US
FORD, Shirin, K., US
|
| (73) |
Genomic Health, Inc.,
301 Penobscot Drive, Redwood City, CA 94063,
US
Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, NJ 08543, US |
| (54) | PREDICTORS OF PATIENT RESPONSE TO TREATMENT WITH EGF RECEPTOR INHIBITORS |
| PREDICTORS OF PATIENT RESPONSE TO TREATMENT WITH EGF RECEPTOR INHIBITORS |